MREO Mereo BioPharma Group plc - American Depositary Shares
$0,31
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 11, 2026
52W-Spanne
$0–$2
5% of range
Analystenbewertung
STRONG BUY
14 analysts
Kursziel
$2
+540% upside
P/E (TTM)
-6.2
ROE
-88.1%
Nettogewinnmarge
-8375.6%
MREO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$0.31
Marktkapitalisierung
$248M
P/E (TTM)
-6.2
EPS (TTM)
$-0.05
Umsatz (TTM)
$500.0K
Dividendenrendite
—
ROE
-88.1%
Verschuldungsgrad
—
52W-Spanne
$0 – $2
MREO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$500.0K
2022-12-31
→
2025-12-31
EPS
$-0.05
2022-12-31
→
2025-12-31
Freier Cashflow
$-31M
2023-12-31
→
2025-12-31
Margen
-8375.6%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
MREO
Peer-Median
P/E (TTM)
-6.2
—
P/S (TTM) (K/V (TTM))
495.8
1305.2
P/B (K/B)
6.1
4.4
Price / FCF (Kurs / FCF)
-8.0
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
MREO
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-8021.4%
—
Net Profit Margin (Nettogewinnmarge)
-8375.6%
-1841.7%
ROA
-68.5%
-38.9%
ROE
-88.1%
-49.6%
ROIC
-98.0%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
MREO
Peer-Median
Current Ratio (Liquiditätsgrad)
10.5
10.5
Quick Ratio
9.5
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
MREO
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
MREO
Peer-Median
MREO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
14 Analysten
- Starker Kauf 5 35,7%
- Kauf 5 35,7%
- Halten 4 28,6%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
5 Analysten · 2026-08-13
Median
$1.98
← Unter allen Zielen
$0.31
Tief
$1.00
Hoch
$3.00
Median-Ziel
$1.98
+536,7%
Mittelwert-Ziel
$1.99
+539,8%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.03%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.01 | $-0.01 | 0.00% |
| 31. Dezember 2025 | $-0.01 | $-0.01 | 0.00% |
| 30. September 2025 | $-0.01 | $-0.02 | 0.01% |
| 30. Juni 2025 | $-0.10 | $-0.02 | -0.08% |
| 31. März 2025 | $-0.10 | $-0.01 | -0.09% |
| 31. Dezember 2024 | $-0.05 | $-0.01 | -0.04% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| MREO | $332M | -8.3 | — | -8375.6% | -88.1% | — |
| OKYO | — | — | — | — | — | — |
| BRNS | $29M | -0.4 | 1766.5% | — | -65.0% | — |
| ROIV | $19.95B | -51.3 | -71.6% | -3629.2% | -6.5% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $500.0K | $0 | $10M | $0 | |
| R&D Expense | $18M | $21M | $17M | $29M | |
| SG&A Expense | $23M | $26M | $18M | $26M | |
| Operating Income | $-40M | $-47M | $-28M | $-54M | |
| Interest Expense | $255.0K | $1M | $3M | $4M | |
| Interest Income | $104.0K | $0 | $2M | $840.0K | |
| Other Non-op | $300.0K | $0 | $-10.0K | $1M | |
| Pretax Income | $-42M | $-43M | $-30M | $-43M | |
| Income Tax | $0 | $0 | $-532.0K | $-718.0K | |
| Net Income | $-42M | $-43M | $-29M | $-42M | |
| EPS (Basic) | $-0.05 | $-0.06 | $-0.04 | $-0.07 | |
| EPS (Diluted) | $-0.05 | $-0.06 | $-0.04 | $-0.07 | |
| Shares (Basic) | 797,119,632 | 739,624,264 | 659,453,921 | 603,196,403 | |
| Shares (Diluted) | 797,119,632 | 739,624,264 | 659,453,921 | 603,196,403 | |
| EBITDA | $-40M | $-47M | $-28M | · |
Bilanz 22
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $70M | $57M | $68M | |
| Prepaid Expense | $3M | $2M | $5M | $5M | |
| Current Assets | $45M | $75M | $64M | $75M | |
| PP&E (Net) | $137.0K | $257.0K | $405.0K | $551.0K | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | |
| Accum. Depreciation | $1M | $949.0K | $800.0K | $736.0K | |
| Intangibles | $516.0K | $643.0K | $1M | $0 | |
| Total Assets | $46M | $76M | $66M | $77M | |
| Accounts Payable | $1M | $2M | $2M | $3M | |
| Accrued Liabilities | $2M | $4M | $5M | $5M | |
| Current Liabilities | $4M | $14M | $9M | $24M | |
| Capital Leases | $0 | $187.0K | $906.0K | $1M | |
| Other Non-current Liabilities | $661.0K | $565.0K | $764.0K | $0 | |
| Total Liabilities | $5M | $15M | $16M | $26M | |
| Common Stock | $3M | $3M | $3M | $2M | |
| Paid-in Capital | $550M | $540M | $486M | $477M | |
| Retained Earnings | $-501M | $-463M | $-420M | $-405M | |
| Treasury Stock | · | $0 | $1M | $1M | |
| AOCI | $-11M | $-19M | $-17M | $-22M | |
| Stockholders' Equity | $41M | $61M | $51M | $51M | |
| Liabilities + Equity | $46M | $76M | $66M | $77M | |
| Shares Outstanding | 795,658,504 | 775,728,034 | 701,217,089 | 624,928,519 |
Cashflow 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $8M | $7M | $5M | $5M | |
| Deferred Tax | · | $0 | $0 | $0 | |
| Amort. of Intangibles | $465.0K | $438.0K | $395.0K | $0 | |
| Operating Cash Flow | $-31M | $-33M | $-21M | $-49M | |
| CapEx | $20.0K | $0 | $0 | $13.0K | |
| Investing Cash Flow | $-20.0K | $-699.0K | $-419.0K | $2M | |
| Stock Issued | $39.0K | $47M | $12M | $0 | |
| Net Stock Activity | $39.0K | $47M | $12M | · | |
| Financing Cash Flow | $327.0K | $46M | $8M | $200.0K | |
| Net Change in Cash | · | $12M | $-11M | · | |
| Taxes Paid | · | $0 | $-1M | $2M | |
| Free Cash Flow | $-31M | · | $-21M | · | |
| Levered FCF | $-31M | · | $-24M | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -8021.4% | · | -284.2% | · | |
| Net Margin | -8375.6% | · | -294.7% | · | |
| Pretax Margin | -8375.6% | · | -300.0% | · | |
| EBITDA Margin | -8021.4% | · | -284.2% | · | |
| ROA | -68.5% | -60.5% | -40.9% | · | |
| ROE | -88.1% | 747.9% | -56.0% | · | |
| ROIC | -98.0% | -77.7% | -55.2% | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 10.5 | 5.4 | 6.7 | · | |
| Quick Ratio | 9.5 | 5.0 | 6.1 | · | |
| Interest Coverage | -157.3 | -34.6 | -9.9 | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $500.0K | $0 | $10M | · | |
| Net Income TTM | $-42M | $-43M | $-29M | · | |
| Market Cap | $332M | $2.72B | $1.62B | · | |
| P/E | -8.3 | -58.3 | -57.8 | · | |
| P/S | 663.6 | · | 162.0 | · | |
| P/B | 8.1 | 44.5 | 32.1 | · | |
| P / Tangible Book | 8.2 | 45.0 | 32.8 | · | |
| P / Cash Flow | -10.7 | -82.7 | -76.7 | · | |
| P / FCF | -10.7 | · | -76.7 | · | |
| Earnings Yield | -12.0% | -1.7% | -1.7% | · |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | · | $0 | $0 | $500.0K | · | $0 | $0 | $0 | $0 | $1M | $0 | $9M | $0 | |
| R&D Expense | $2M | $5M | $4M | $4M | $5M | $4M | $9M | $3M | $5M | $4M | $5M | $4M | $4M | $5M | |
| SG&A Expense | $5M | $4M | $4M | $6M | $5M | $7M | $6M | $6M | $8M | $6M | $4M | $6M | $3M | $6M | |
| Operating Income | $-7M | $-9M | $-8M | $-10M | $-10M | $-11M | $-15M | $-9M | $-13M | $-10M | $-7M | $-9M | $-811.0K | $-11M | |
| Interest Expense | $16.0K | $20.0K | $23.0K | $28.0K | $24.0K | $180.0K | $376.0K | $353.0K | $331.0K | $310.0K | $352.0K | $700.0K | $1M | $800.0K | |
| Interest Income | $19.0K | $31.0K | $70.0K | $-1M | $589.0K | $0 | $-2M | $983.0K | $559.0K | $617.0K | $763.0K | $689.0K | $373.0K | $306.0K | |
| Other Non-op | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-4.0K | $0 | $0 | $-6.0K | |
| Pretax Income | $-7M | $-7M | $-7M | $-7M | $-15M | $-13M | $-7M | $-15M | $-12M | $-9M | $-10M | $-7M | $-2M | $-12M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-532.0K | $0 | $0 | $0 | |
| Net Income | $-7M | $-7M | $-7M | $-7M | $-15M | $-13M | $-7M | $-15M | $-12M | $-9M | $-9M | $-7M | $-2M | $-12M | |
| EPS (Basic) | $-0.01 | $-0.01 | $0.00 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $0.00 | $-0.02 | |
| EPS (Diluted) | $-0.01 | $-0.01 | $0.00 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $0.00 | $-0.02 | |
| Shares (Basic) | 803,562,708 | 801,805,570 | -1,586,542,097 | 799,947,013 | 799,435,329 | 784,279,387 | -1,500,932,404 | 770,146,589 | 770,146,589 | 700,263,490 | -1,277,866,968 | 684,974,190 | 628,421,064 | 623,925,635 | |
| Shares (Diluted) | 803,562,708 | 801,805,570 | -1,586,542,097 | 799,947,013 | 799,435,329 | 784,279,387 | -1,500,932,404 | 770,146,589 | 770,146,589 | 700,263,490 | -1,277,866,968 | 684,974,190 | 628,421,064 | 623,925,635 | |
| EBITDA | $-7M | $-9M | · | $-10M | $-10M | $-11M | · | $-9M | $-13M | $-10M | · | · | · | · |
Bilanz 22
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $36M | $41M | $49M | $56M | $62M | $70M | $81M | $87M | $49M | $57M | · | · | · | |
| Prepaid Expense | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $4M | $4M | $3M | $5M | · | · | · | |
| Current Assets | $33M | $40M | $45M | $52M | $61M | $67M | $75M | $87M | $94M | $53M | $64M | · | · | · | |
| PP&E (Net) | $54.0K | $91.0K | $137.0K | $174.0K | $218.0K | $247.0K | $257.0K | $315.0K | $338.0K | $360.0K | $405.0K | · | · | · | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | · | · | |
| Accum. Depreciation | $1M | $978.0K | $1M | $1M | $1M | $1M | $949.0K | $964.0K | $877.0K | $836.0K | $800.0K | · | · | · | |
| Intangibles | $256.0K | $381.0K | $516.0K | $643.0K | $470.0K | $554.0K | $643.0K | $799.0K | $866.0K | $972.0K | $1M | · | · | · | |
| Total Assets | $35M | $41M | $46M | $54M | $63M | $68M | $76M | $89M | $96M | $56M | $66M | · | · | · | |
| Accounts Payable | $1M | $3M | $1M | $879.0K | $1M | $3M | $2M | $2M | $3M | $2M | $2M | · | · | · | |
| Accrued Liabilities | $2M | $2M | $2M | $4M | $5M | $3M | $4M | $4M | $4M | $3M | $5M | · | · | · | |
| Current Liabilities | $6M | $6M | $4M | $6M | $8M | $7M | $14M | $14M | $15M | $11M | $9M | · | · | · | |
| Capital Leases | $0 | · | $0 | $0 | $0 | $0 | $187.0K | $394.0K | $552.0K | $727.0K | $906.0K | · | · | · | |
| Other Non-current Liabilities | $370.0K | $362.0K | $661.0K | $652.0K | $352.0K | $325.0K | $565.0K | $568.0K | $536.0K | $513.0K | $764.0K | · | · | · | |
| Total Liabilities | $6M | $7M | $5M | $7M | $8M | $8M | $15M | $16M | $17M | $13M | $16M | · | · | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | · | · | |
| Paid-in Capital | $552M | $551M | $550M | $548M | $546M | $544M | $540M | $536M | $535M | $487M | $486M | · | · | · | |
| Retained Earnings | $-515M | $-508M | $-501M | $-494M | $-487M | $-472M | $-463M | $-456M | $-441M | $-429M | $-420M | · | · | · | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $0 | $0 | $1M | · | · | · | |
| AOCI | $-12M | $-13M | $-11M | $-11M | $-9M | $-15M | $-19M | $-11M | $-18M | $-18M | $-17M | · | · | · | |
| Stockholders' Equity | $29M | $34M | $41M | $47M | $54M | $60M | $61M | $73M | $79M | $43M | $51M | · | · | · | |
| Liabilities + Equity | $35M | $41M | $46M | $54M | $63M | $68M | $76M | $89M | $96M | $56M | $66M | · | · | · | |
| Shares Outstanding | 798,093,044 | 798,078,829 | 795,658,504 | 795,484,404 | 795,001,444 | 795,001,444 | 775,728,034 | 773,672,299 | 768,821,274 | 701,349,434 | 701,217,089 | · | · | · |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $815.0K | $2M | $941.0K | $2M | |
| Amort. of Intangibles | $127.0K | $127.0K | $424.0K | $-183.0K | $118.0K | $106.0K | $110.0K | $112.0K | $108.0K | $108.0K | $115.0K | $109.0K | $107.0K | $64.0K | |
| Operating Cash Flow | $-6M | $-4M | $-8M | $-7M | $-8M | $-8M | $-9M | $-8M | $-8M | $-8M | $-7M | $3M | $-8M | $-9M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $20.0K | $0 | $0 | $0 | $0 | · | · | · | · | |
| Investing Cash Flow | $0 | $-300.0K | $0 | $300.0K | $0 | $-320.0K | $0 | $0 | $1.0K | $-700.0K | $0 | $0 | $0 | $-419.0K | |
| Stock Issued | · | · | $39.0K | $0 | · | · | $0 | $0 | · | · | $0 | $12M | · | · | |
| Financing Cash Flow | $0 | $0 | $39.0K | $0 | $-134.0K | $422.0K | $-40.0K | $-594.0K | $47M | $0 | $0 | $8M | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | |
| Taxes Paid | · | · | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $37.0K | |
| Free Cash Flow | · | $-4M | · | · | · | $-8M | · | · | · | · | · | · | · | · | |
| Levered FCF | · | $-4M | · | · | · | $-9M | · | · | · | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -2099.8% | · | · | · | · | · | · | · | · | · | |
| Net Margin | · | · | · | · | -2923.2% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | · | · | · | · | -2923.2% | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | -2099.8% | · | · | · | · | · | · | · | · | · | |
| ROA | -14.4% | -12.3% | · | -9.9% | -18.4% | -20.7% | · | -33.8% | -25.5% | -32.0% | · | · | · | · | |
| ROE | -16.9% | -14.3% | · | -11.8% | -22.0% | -25.0% | · | -41.4% | -31.2% | -41.8% | · | · | · | · | |
| ROIC | -24.5% | -25.7% | · | -21.5% | -19.4% | -18.6% | · | -12.9% | -16.3% | -23.1% | · | · | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 6.5 | · | 8.7 | 8.1 | 8.9 | · | 6.1 | 6.1 | 4.9 | · | · | · | · | |
| Quick Ratio | 5.3 | 5.9 | · | 8.1 | 7.4 | 8.3 | · | 5.7 | 5.7 | 4.4 | · | · | · | · | |
| Interest Coverage | -439.4 | -438.3 | · | -357.7 | -437.5 | -62.2 | · | -26.6 | -38.7 | -31.9 | · | · | · | · |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | $0 | · | $0 | $9M | $9M | · | · | · | · | |
| Net Income TTM | $-35M | $-41M | · | $-50M | $-55M | $-49M | · | $-43M | $-29M | $-29M | · | · | · | · | |
| Market Cap | $254M | $263M | · | $1.64B | $2.15B | $1.79B | · | $3.18B | $2.77B | $2.31B | · | · | · | · | |
| P/E | -6.4 | -5.5 | · | -29.4 | -33.9 | -32.1 | · | -68.5 | -90.0 | -82.5 | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | · | 307.5 | 257.2 | · | · | · | · | |
| P/B | 8.9 | 7.7 | · | 35.2 | 39.8 | 29.8 | · | 43.8 | 35.2 | 54.0 | · | · | · | · | |
| P / Tangible Book | 8.9 | 7.8 | · | 35.7 | 40.1 | 30.0 | · | 44.3 | 35.6 | 55.3 | · | · | · | · | |
| P / Cash Flow | · | -61.1 | · | · | · | -214.8 | · | · | · | -289.6 | · | · | · | · | |
| P / FCF | · | -61.1 | · | · | · | -214.2 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -15.7% | -18.2% | · | -3.4% | -2.9% | -3.1% | · | -1.5% | -1.1% | -1.2% | · | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Umsatz | $500.0K | $0 | $10M | $0 |
| Betriebsgewinnmarge % | -8021.4% | — | -284.2% | — |
| Nettoergebnis | $-42M | $-43M | $-29M | $-42M |
| Verwässerte EPS | $-0.05 | $-0.06 | $-0.04 | $-0.07 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Liquiditätsgrad | 10.5 | 5.4 | 6.7 | — |
| Quick Ratio | 9.5 | 5.0 | 6.1 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Freier Cashflow | $-31M | — | $-21M | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 68 Einreicher · $17.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 15 (-1 vs. Vorquartal) | 17 (-6 vs. Vorquartal) | 15 (-3 vs. Vorquartal) | 15 (0 vs. Vorquartal) | -18.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Rubric Capital Management LP | $4.863.144 | 15.307.347 | 27,62% | Aktien |
| 683 Capital Management, LLC | $3.741.825 | 11.777.856 | 21,25% | Aktien |
| BANK OF AMERICA CORP /DE/ | $2.597.904 | 8.195.281 | 14,75% | Aktien |
| Defilade Capital Management, L.P. | $2.401.417 | 7.558.756 | 13,64% | Aktien |
| Newtyn Management, LLC | $953.100 | 3.000.000 | 5,41% | Aktien |
| Tejara Capital Ltd | $647.320 | 2.037.520 | 3,68% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $419.123 | 1.319.241 | 2,38% | Aktien |
| EcoR1 Capital, LLC | $317.700 | 1.000.000 | 1,80% | Aktien |
| Ishara Investments LP | $244.232 | 768.750 | 1,39% | Aktien |
| Wealthspire Advisors, LLC | $243.041 | 765.000 | 1,38% | Aktien |
| CITADEL ADVISORS LLC | $160.407 | 504.900 | 0,91% | Kaufoption |
| JANE STREET GROUP, LLC | $154.711 | 486.971 | 0,88% | Aktien |
| TWO SIGMA ADVISERS, LP | $104.967 | 251.900 | 0,60% | Aktien |
| Rangeley Capital, LLC | $104.587 | 329.200 | 0,59% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $67.756 | 213.270 | 0,38% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55.520 | 173.500 | 0,32% | Kaufoption |
| XTX Topco Ltd | $55.433 | 174.481 | 0,31% | Aktien |
| GROUP ONE TRADING LLC | $53.220 | 167.515 | 0,30% | Aktien |
| STATE STREET CORP | $42.817 | 134.772 | 0,24% | Aktien |
| Sheets Smith Investment Management | $34.793 | 16.890 | 0,20% | Aktien |
| NOMURA HOLDINGS INC | $33.155 | 104.361 | 0,19% | Aktien |
| James J. Burns & Company, LLC | $30.309 | 95.400 | 0,17% | Aktien |
| Quarry LP | $29.784 | 93.750 | 0,17% | Aktien |
| GOLDMAN SACHS GROUP INC | $27.062 | 85.180 | 0,15% | Aktien |
| JMN Financial LLC | $24.383 | 76.748 | 0,14% | Aktien |
| BlackRock, Inc. | $22.137 | 69.678 | 0,13% | Aktien |
| JPMORGAN CHASE & CO | $18.887 | 56.923 | 0,11% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $16.552 | 52.100 | 0,09% | Aktien |
| CITADEL ADVISORS LLC | $16.203 | 51.000 | 0,09% | Verkaufsoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14.720 | 46.000 | 0,08% | Verkaufsoption |
| MARSHALL WACE, LLP | $10.532 | 32.913 | 0,06% | Aktien |
| Significant Wealth Partners LLC | $10.382 | 32.677 | 0,06% | Aktien |
| Clear Harbor Asset Management, LLC | $10.083 | 32.000 | 0,06% | Aktien |
| RHUMBLINE ADVISERS | $8.511 | 26.784 | 0,05% | Aktien |
| Centiva Capital, LP | $7.943 | 25.000 | 0,05% | Aktien |
| Engineers Gate Manager LP | $7.610 | 23.953 | 0,04% | Aktien |
| SIMPLEX TRADING, LLC | $5.972 | 18.780 | 0,03% | Aktien |
| NFSG Corp | $5.957 | 18.750 | 0,03% | Aktien |
| OneDigital Investment Advisors LLC | $5.814 | 18.300 | 0,03% | Aktien |
| IHT Wealth Management, LLC | $4.766 | 15.000 | 0,03% | Aktien |
| CITADEL ADVISORS LLC | $4.250 | 13.378 | 0,02% | Aktien |
| TWO SIGMA SECURITIES, LLC | $4.098 | 12.900 | 0,02% | Aktien |
| J. Safra Sarasin Holding AG | $4.081 | 12.841 | 0,02% | Aktien |
| MML INVESTORS SERVICES, LLC | $3.876 | 12.200 | 0,02% | Aktien |
| JANE STREET GROUP, LLC | $3.749 | 11.800 | 0,02% | Kaufoption |
| World Investment Advisors | $3.300 | 10.000 | 0,02% | Aktien |
| Astoria Portfolio Advisors LLC. | $3.177 | 10.000 | 0,02% | Aktien |
| GAMMA Investing LLC | $2.957 | 9.308 | 0,02% | Aktien |
| UBS Group AG | $1.880 | 5.912 | 0,01% | Aktien |
| Arax Advisory Partners | $1.849 | 5.819 | 0,01% | Aktien |
| Rockefeller Capital Management L.P. | $635 | 2.000 | 0,00% | Aktien |
| Allworth Financial LP | $477 | 1.500 | 0,00% | Aktien |
| OSAIC HOLDINGS, INC. | $320 | 1.000 | 0,00% | Aktien |
| New England Capital Financial Advisors LLC | $96 | 300 | 0,00% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $71 | 225 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $36 | 114 | 0,00% | Aktien |
| EverSource Wealth Advisors, LLC | $32 | 100 | 0,00% | Aktien |
| Virtu Financial LLC | $19 | 61.285 | 0,00% | Aktien |
| CITIGROUP INC | $17 | 52 | 0,00% | Aktien |
| US BANCORP \DE\ | $4 | 13 | 0,00% | Aktien |
| SG Americas Securities, LLC | $4 | 12.802 | 0,00% | Aktien |
| MORGAN STANLEY | $1 | 1 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1 | 3 | 0,00% | Aktien |
| Integrated Wealth Concepts LLC | $0 | 1 | 0,00% | Aktien |
| Axiom Investment Management LLC | $0 | 1 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $0 | 1 | 0,00% | Aktien |
| SIT INVESTMENT ASSOCIATES INC | $0 | 970 | 0,00% | Aktien |
| WELLS FARGO & COMPANY/MN | $0 | 1 | 0,00% | Aktien |
Unternehmensinsider 13 Insider · 5 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Denise Scots-Knight | Chief Executive Officer | 1. Februar 2026 A | 808.921 | 0 | 0 | $0 |
| Chrisitne Ann Fox | Chief Financial Officer | 1. Februar 2026 A | 89.285 | 0 | 0 | $0 |
| Alexandra Hughes-Wilson | Chief Patient Access and Commercial Planning | 1. Februar 2026 A | 50.475 | 0 | 0 | $0 |
| Charles Sermon | General Counsel | 1. Februar 2026 A | 219.061 | 0 | 0 | $0 |
| John A. Lewicki | Chief Scientific Officer | 1. Februar 2026 A | 78.630 | 0 | 0 | $0 |
| Anders Ekblom | Direktor | 26. Februar 2026 A | — | 0 | 0 | $0 |
| Daniel Shames | Direktor | 26. Februar 2026 A | — | 0 | 0 | $0 |
| Jeremy Bender | Direktor | 26. Februar 2026 A | 12.550 | 0 | 0 | $0 |
| Pierre Jacquet | Direktor | 26. Februar 2026 A | — | 0 | 0 | $0 |
| Annalisa Jenkins | Direktor | 26. Februar 2026 A | — | 0 | 0 | $0 |
| Marc J Yoskowitz | Direktor | 26. Februar 2026 A | — | 0 | 0 | $0 |
| Deepika Pakianathan | Direktor | 26. Februar 2026 A | 0 | 0 | 0 | $0 |
| Michael S Wyzga | Direktor | 26. Februar 2026 A | 25.050 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Rubric Capital Management LP, David Rosen ×16 Einreichungen | 17. Juni 2024 | — | Erste Einreichung | — | SEC |
| Mereo BioPharma Group plc, Dr. Denise Scots-Knight | 17. Dezember 2018 | — | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 1 ETF
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,09% | 127.193 NS | 30. April 2026 | N-PORT |